“Our strategy is to continue our long track record of growth by being the ‘go to’ European specialist pharma company partner of choice. We acquire, develop and commercialise specialist and transformative products through our infrastructure  that add value to healthcare systems and make a difference to patients. “

Peter Stein
CEO, Norgine



Strategic priorities

Achieve strong sustainable growth


Maintain strong late stage pipeline


Be a dynamic place to work


Collaborating with partners who share our vision for improving healthcare

Partner for a healthy life